Literature DB >> 19652527

Alteration of tumor spectrum by ISGylation in p53-deficient mice.

Xiaoyan Yin1, Xiuli Cong, Ming Yan, Dong-Er Zhang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652527     DOI: 10.4161/cbt.8.12.8558

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  6 in total

1.  Type I IFN induces protein ISGylation to enhance cytokine expression and augments colonic inflammation.

Authors:  Jun-Bao Fan; Sayuri Miyauchi-Ishida; Kei-ichiro Arimoto; Dan Liu; Ming Yan; Chang-Wei Liu; Balázs Győrffy; Dong-Er Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-29       Impact factor: 11.205

2.  The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy.

Authors:  Laurence M Wood; Zhen-Kun Pan; Matthew M Seavey; Geetha Muthukumaran; Yvonne Paterson
Journal:  Cancer Immunol Immunother       Date:  2011-11-06       Impact factor: 6.968

3.  Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15.

Authors:  Young Joo Jeon; Mi Gyeong Jo; Hee Min Yoo; Se-Hoon Hong; Jung-Mi Park; Seung Hyeun Ka; Kyu Hee Oh; Jae Hong Seol; Yong Keun Jung; Chin Ha Chung
Journal:  J Clin Invest       Date:  2012-06-18       Impact factor: 14.808

Review 4.  Interferon-stimulated gene 15 and the protein ISGylation system.

Authors:  Dongxian Zhang; Dong-Er Zhang
Journal:  J Interferon Cytokine Res       Date:  2010-12-29       Impact factor: 2.607

Review 5.  ISG15 and immune diseases.

Authors:  Young Joo Jeon; Hee Min Yoo; Chin Ha Chung
Journal:  Biochim Biophys Acta       Date:  2010-02-12

Review 6.  ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system.

Authors:  Chaohui Zuo; Xinyi Sheng; Min Ma; Man Xia; Linda Ouyang
Journal:  Oncotarget       Date:  2016-11-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.